Testing Implementation of Total Joint Replacement Rehabilitation Quality Indicator Toolkits
Launched by UNIVERSITY OF BRITISH COLUMBIA · Jan 5, 2024
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at new tools to help improve the rehabilitation process for patients who have had hip or knee replacement surgery. The researchers want to see if the EQUIP toolkit, which is meant for patients, and the QUICK toolkit for healthcare providers are easy to use and helpful in real-life settings. They will also explore how using these tools affects patients' experiences and the quality of care they receive during their recovery.
To participate in this study, you need to be an adult aged 19 or older who has had a hip or knee replacement due to osteoarthritis. You should have completed your rehabilitation at one of the study locations and be able to understand English well enough to give consent and answer some questions. If you join, you will be asked to fill out an online survey about how well you are doing after your rehabilitation, while healthcare providers will also provide feedback on their care practices. This study is still in the planning stages and is not yet recruiting participants, so keep an eye out for updates if you're interested!
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Clinician participants
- • - Physical therapists, rehabilitation assistants, students, and other rehabilitation providers at the study clinical site who provide direct patient care after total joint replacement
- • Patient participants
- • Adults ages 19 and older
- • Primary total hip or knee replacement for osteoarthritis
- • No significant co-morbidities or peri-operative complications that markedly prolonged acute hospital stay or delayed the start of post-acute rehabilitation
- • Sufficient English language skills to provide informed consent and complete questionnaires (with/without help from a family member)
- • Completed their course of supervised rehabilitation at study site
- Exclusion Criteria:
- • Unwilling or unable to provide written informed consent
- • Had another lower limb joint replacement in the previous 6 months
- • Received some of their post-acute rehabilitation at another clinical facility other than the two study sites
- • Received fewer than 3 post-acute rehabilitation visits
About University Of British Columbia
The University of British Columbia (UBC) is a leading research institution located in Vancouver, Canada, renowned for its commitment to advancing health sciences through innovative research and education. As a prominent clinical trial sponsor, UBC leverages its interdisciplinary expertise and state-of-the-art facilities to conduct rigorous clinical studies aimed at improving patient outcomes across various medical fields. The university fosters collaborations with healthcare professionals, industry partners, and community stakeholders to translate research findings into practical applications, thereby contributing to the global advancement of medicine and public health.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Vancouver, British Columbia, Canada
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported